Proveri Management Team

Waldemar Lernhardt, Ph.D
President and Chief Executive Officer
Director

Dr. Lernhardt obtained his Ph.D. from The University of Heidelberg, Germany. His thesis work was performed at the Basel Institute for Immunology in Basel, Switzerland. Postdoctoral research was performed at the Molecular Biology Institute of the University of California at Los Angeles. Following a assistant professorship at the Burnham Institute in La Jolla, CA Dr. Lernhardt held the position of Research Program Director at a not-for-profit affiliate of Stratagene Cloning System. He then spent 5 years in assay development, kit production and marketing at Stratagene Cloning Systems. Dr. Lernhardt has 7 years of experience in managing MAXIA Pharmaceuticals, Inc. from start-up stage to the acquisition by Incyte Corporation. He is a proven leader of an R&D stage organization with demonstrated leadership skills and expertise of running a biotech start-up, from strategic direction to financing and acquisition. He has a track record of bringing products to market, of advancing drug candidates to the partnering stage and acquisition of a development-stage company by larger biotech firm. He has assay development, small molecule drug discovery, development and clinical research experience. Dr. Lernhardt will be responsible for the overall strategic direction of the Company and management of the daily business.